Arcadia Biosciences, Inc. (RKDA) Spending and interest coverage
- R&D / revenue · 12 months: Value 0.00%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 2.09%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 0.00% | Research and development expense / revenue. Period ending 2026-06-30. $0.00 ÷ $4.75M × 100 ≈ 0.00% |
| Stock-based compensation / revenue · 12 months | 2.09% | Share-based compensation / revenue. Period ending 2026-06-30. $99.00K ÷ $4.75M × 100 ≈ 2.09% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 0.00 USD | Research and Development Expense |
| Revenue | 4.75M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 99.00K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -3.80M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $4.75M | $99.00K | $-3.80M | (m) | 0.00% | 2.09% | (m) | (m) |
| 2026-03-31 | (m) | $4.76M | $171.00K | $-3.81M | (m) | (m) | 3.59% | (m) | (m) |
| 2025-12-31 | $9.00K | $4.86M | $234.00K | $-2.50M | (m) | 0.19% | 4.82% | (m) | (m) |
| 2025-09-30 | $22.00K | $5.17M | $334.00K | $-3.40M | (m) | 0.43% | 6.46% | (m) | (m) |
| 2025-06-30 | $46.00K | $5.41M | $436.00K | $-4.01M | (m) | 0.85% | 8.06% | (m) | (m) |
| 2025-03-31 | $47.00K | $5.26M | $452.00K | $-1.53M | (m) | 0.89% | 8.60% | (m) | (m) |
| 2024-12-31 | $53.00K | $5.04M | $512.00K | $-3.65M | (m) | 1.05% | 10.15% | (m) | (m) |
| 2024-09-30 | $1.37M | $5.48M | $539.00K | $-10.40M | (m) | 25.03% | 9.83% | (m) | (m) |
| 2024-06-30 | $1.36M | $5.24M | $546.00K | $-10.04M | (m) | 25.99% | 10.41% | (m) | (m) |
| 2024-03-31 | $1.30M | $5.35M | $643.00K | $-13.13M | (m) | 24.29% | 12.01% | (m) | (m) |
| 2023-12-31 | $1.39M | $5.33M | $717.00K | $-13.94M | (m) | 26.02% | 13.45% | (m) | (m) |
| 2023-09-30 | $1.55M | $7.44M | $782.00K | $-20.04M | (m) | 20.89% | 10.51% | (m) | (m) |
| 2023-06-30 | $1.50M | $5.78M | $934.00K | $-18.25M | (m) | 26.05% | 16.17% | (m) | (m) |
| 2023-03-31 | $1.47M | $8.24M | $1.06M | $-18.24M | (m) | 17.87% | 12.83% | (m) | (m) |
| 2022-12-31 | $1.51M | $9.96M | $1.11M | $-18.82M | (m) | 15.16% | 11.11% | (m) | (m) |
| 2022-09-30 | $1.57M | $11.13M | $1.40M | $-26.79M | (m) | 14.11% | 12.61% | (m) | (m) |
| 2022-06-30 | $2.35M | $11.62M | $1.44M | $-30.92M | (m) | 20.24% | 12.41% | (m) | (m) |
| 2022-03-31 | $3.13M | $9.17M | $1.48M | $-34.82M | $12.00K | 34.07% | 16.09% | -2901.92× | Reported |
| 2021-12-31 | $3.89M | $6.78M | $1.54M | $-35.53M | $20.00K | 57.36% | 22.73% | -1776.30× | Reported |
| 2021-09-30 | $5.29M | $11.74M | $1.23M | $-14.25M | $38.00K | 45.05% | 10.50% | -375.08× | Reported |
| 2021-06-30 | $6.01M | $9.68M | $1.36M | $-13.12M | $46.00K | 62.13% | 14.01% | -285.24× | Reported |
| 2021-03-31 | $6.88M | $8.55M | $1.59M | $-12.31M | $53.00K | 80.38% | 18.65% | -232.34× | Reported |
| 2020-12-31 | $7.96M | $8.03M | $2.04M | $-12.78M | $47.00K | 99.08% | 25.42% | -271.87× | Reported |
| 2020-09-30 | $7.71M | $1.32M | $2.26M | $-24.24M | $34.00K | 584.09% | 171.29% | -712.82× | Reported |
| 2020-06-30 | $7.88M | $1.40M | $2.84M | $-22.85M | $14.00K | 563.59% | 203.36% | -1631.93× | Reported |
| 2020-03-31 | $7.84M | $1.32M | $2.64M | $-20.95M | (m) | 593.71% | 199.77% | (m) | (m) |
| 2019-12-31 | $7.10M | $1.17M | $2.29M | $-19.38M | $5.00K | 607.19% | 195.64% | -3876.20× | Reported |
| 2019-09-30 | $6.93M | $1.20M | $2.42M | $-19.75M | (m) | 579.11% | 202.34% | (m) | (m) |
| 2019-06-30 | $6.33M | $1.18M | $1.71M | $-17.65M | (m) | 539.15% | 145.11% | (m) | (m) |
| 2019-03-31 | $6.18M | $1.41M | $1.67M | $-17.25M | (m) | 438.78% | 118.89% | (m) | (m) |
| 2018-12-31 | $6.07M | $1.46M | $1.55M | $-16.87M | (m) | 414.55% | 105.87% | (m) | (m) |
| 2018-09-30 | $6.69M | (m) | $1.29M | $-15.52M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $7.11M | (m) | $1.37M | $-15.03M | $43.00K | (m) | (m) | -349.58× | Reported |
| 2018-03-31 | $6.98M | $3.22M | $1.40M | $-14.19M | (m) | 216.64% | 43.48% | (m) | (m) |
| 2017-12-31 | $7.41M | $4.03M | $1.47M | $-14.31M | $747.00K | 183.98% | 36.61% | -19.16× | Reported |
| 2017-09-30 | $7.23M | $3.14M | $1.57M | $-16.79M | $1.08M | 230.43% | 50.19% | -15.53× | Reported |
| 2017-06-30 | $7.74M | $3.62M | $1.43M | $-17.10M | $1.37M | 213.49% | 39.35% | -12.49× | Reported |
| 2017-03-31 | $8.28M | $3.35M | $1.21M | $-17.65M | $1.33M | 246.99% | 36.05% | -13.26× | Reported |
| 2016-12-31 | $8.66M | $3.19M | $1.06M | $-18.62M | $1.32M | 271.74% | 33.22% | -14.12× | Reported |
| 2016-09-30 | $8.54M | $3.99M | $848.00K | $-17.22M | $1.64M | 213.87% | 21.23% | -10.53× | Reported |
| 2016-06-30 | $9.47M | $4.74M | $861.00K | $-17.53M | $2.07M | 199.62% | 18.16% | -8.47× | Reported |
| 2016-03-31 | $9.34M | $5.45M | $1.23M | $-16.79M | $2.52M | 171.27% | 22.49% | -6.67× | Reported |
| 2015-12-31 | $8.97M | $5.41M | $1.39M | $-15.56M | $2.66M | 165.61% | 25.71% | -5.86× | Reported |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $10.01M | $6.98M | $976.00K | $-15.15M | $1.39M | 143.40% | 13.98% | -10.87× | Reported |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| New Concept Energy, Inc. (GBR) | United States | $0.004B | |
| Trio Petroleum Corp (TPET) | United States | $0.009B | |
| AleAnna, Inc. (ANNA) | United States | $0.013B | |
| BARNWELL INDUSTRIES INC (BRN) | United States | $0.014B | -2.71 |
| CKX LANDS, INC. (CKX) | United States | $0.022B | 7.62 |
| MEXCO ENERGY CORP (MXC) | United States | $0.022B | 10.07 |
| EON Resources Inc. (EONR) | United States | $0.026B | |
| Prairie Operating Co. (PROP) | United States | $0.047B | -1.72 |
| ABUNDIA GLOBAL IMPACT GROUP, INC. (AGIG) | United States | $0.057B | -1.20 |
| BATTALION OIL CORP (BATL) | United States | $0.064B |